Literature DB >> 8841402

A functional heme-binding site of soluble guanylyl cyclase requires intact N-termini of alpha 1 and beta 1 subunits.

J Foerster1, C Harteneck, J Malkewitz, G Schultz, D Koesling.   

Abstract

Soluble guanylyl cyclase, a heterodimeric enzyme, is the most important intracellular target for the signalling molecule nitric oxide (NO). NO stimulates the enzyme by binding to a prosthetic heme group. The identity of the axial heme ligand, however, is still unknown. Here we show that guanylyl cyclase mutated at the residue His 105 on the beta 1 subunit, a mutant that we have shown before to contain no heme after purification [Wedel, B., Humbert, P., Harteneck, C., Foerster, J., Malkewitz, J., Böhme, E., Schultz, G. & Koesling, D. (1994) Proc. Natl Acad. Sci. USA 91, 2592-2596] can be reconstituted with heme. The reconstituted mutant remains NO-insensitive and displays an ultraviolet absorption spectrum consistent with an altered axial coordination. Thus, this residue is a strong candidate for the axial heme-ligating residue and appears to be necessary for NO stimulation. Apart from the axial heme ligand, the role of the enzyme's two subunits, alpha 1 and beta 1, in heme binding has not been clarified to date. To address this question, we purified mutant heterodimers in which the non-conserved amino termini of either alpha 1 (131 residues deleted), or beta 1 (64 residues) have been deleted. These deletion mutants had previously been found to be marginally (alpha 1 truncated) or not at all NO sensitive (beta 1 truncated) in cytosolic fractions [Wedel, B., Harteneck, C., Foerster, J., Friebe, A., Schultz, G. & Koesling, D. (1995) J. Biol. Chem. 270, 24871-24875]. Here, we show that the purified enzyme truncated on alpha 1 has a significantly reduced capacity to bind heme which explains the reduced NO sensitivity. By contrast, the beta 1-truncated enzyme binds an amount of heme comparable to the wild type but is only marginally NO-responsive and displays a shift in the heme ultraviolet absorption maximum indicative of altered heme coordination. In conclusion, the heme binding site of soluble guanylyl cyclase requires the presence of both subunits in full length to be able to bind wild-type quantities of heme and to be capable of mediating the NO-heme-induced stimulation. Despite some structural similarity, both subunits appear to participate differently in NO-heme-mediated enzyme regulation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8841402     DOI: 10.1111/j.1432-1033.1996.0380h.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  28 in total

Review 1.  The receptor-like properties of nitric oxide-activated soluble guanylyl cyclase in intact cells.

Authors:  Tomas C Bellamy; John Garthwaite
Journal:  Mol Cell Biochem       Date:  2002-01       Impact factor: 3.396

Review 2.  Isoforms of NO-sensitive guanylyl cyclase.

Authors:  Michael Russwurm; Doris Koesling
Journal:  Mol Cell Biochem       Date:  2002-01       Impact factor: 3.396

Review 3.  Soluble guanylate cyclase modulators in heart failure.

Authors:  Veselin Mitrovic; Ana Jovanovic; Stefan Lehinant
Journal:  Curr Heart Fail Rep       Date:  2011-03

4.  Heterogeneous nuclear ribonucleoprotein A1 is a novel cellular target of atrial natriuretic peptide signaling in renal epithelial cells.

Authors:  Bahar Hesabi; Robert S Danziger; Kumar U Kotlo
Journal:  Cell Signal       Date:  2012-01-17       Impact factor: 4.315

Review 5.  NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential.

Authors:  Oleg V Evgenov; Pál Pacher; Peter M Schmidt; György Haskó; Harald H H W Schmidt; Johannes-Peter Stasch
Journal:  Nat Rev Drug Discov       Date:  2006-09       Impact factor: 84.694

6.  Probing the presence of the ligand-binding haem in cellular nitric oxide receptors.

Authors:  B Roy; E Mo; J Vernon; J Garthwaite
Journal:  Br J Pharmacol       Date:  2008-01-21       Impact factor: 8.739

Review 7.  Role of guanylate cyclase modulators in decompensated heart failure.

Authors:  Veselin Mitrovic; Adrian F Hernandez; Markus Meyer; Mihai Gheorghiade
Journal:  Heart Fail Rev       Date:  2009-12       Impact factor: 4.214

8.  Evidence for cross-talk between atrial natriuretic peptide and nitric oxide receptors.

Authors:  Kumar U Kotlo; Mark M Rasenick; Robert S Danziger
Journal:  Mol Cell Biochem       Date:  2009-12-19       Impact factor: 3.396

9.  Sensitizing soluble guanylyl cyclase to become a highly CO-sensitive enzyme.

Authors:  A Friebe; G Schultz; D Koesling
Journal:  EMBO J       Date:  1996-12-16       Impact factor: 11.598

10.  Stimulation of soluble guanylate cyclase by superoxide dismutase is mediated by NO.

Authors:  A Friebe; G Schultz; D Koesling
Journal:  Biochem J       Date:  1998-11-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.